abstract |
The present invention provides a method of reducing a nasal polyp score in a subject. The method includes administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4R) antagonist, such as an anti-IL-4R antibody or antigen-binding fragment thereof. |